PMEF
IDXX icon

Point72 Middle East FZE’s Idexx Laboratories IDXX Stock Holding History

Point72 Middle East FZE’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,300
Closed -$2.94M – 634
2023
Q4 		$2.94M Buy
+5,300
New +$2.49M 0.09% 310
2023
Q2 		– Sell
-2,600
Closed -$1.3M – 1789
2023
Q1 		$1.3M Buy
2,600
+1,300
+100% +$622K 0.04% 431
2022
Q4 		$530K Buy
+1,300
New +$505K 0.02% 711

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Middle East FZE's IDXX Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Idexx Laboratories (IDXX) in Q1 2024, closing a stake of 2,830 shares — an estimated $1.57M sold.

Point72 Middle East FZE first reported a position in IDXX in Q4 2022 and held it in 2 quarters. The position peaked at $2.49M in Q4 2022. 1,149 funds tracked by Wall St. Rank hold IDXX as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Idexx Laboratories position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 2,830 Idexx Laboratories shares in Q1 2024, an estimated $1.57M.
  • Point72 Middle East FZE first reported a position in Idexx Laboratories in Q4 2022 and held it in 2 quarters.
  • Point72 Middle East FZE's Idexx Laboratories position peaked at $2.49M in Q4 2022.
  • 1,149 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.